Risk of serious adverse events associated with biologic and non-biologic psoriasis systemic therapy: real life compared with patients eligible for randomized clinical trials. Results of the BIOBADADERM registry

被引：0
|
作者：
Garcia-Doval, Ignacio [1 ]
Carretero, Gregorio [2 ]
Vanaclocha, Francisco [3 ]
Ferrandiz, Carlos [4 ]
Dauden, Esteban [5 ]
Sanchez-Carazo, Jose-Luis [6 ]
Alsina, Merce [7 ]
Herrera-Ceballos, Enrique [8 ]
Gomez-Garcia, Francisco-Jose [9 ]
机构：
[1] Complexo Hosp Pontevedra, Pontevedra, Spain
[2] Hosp Univ Gran Canaria Dr Negrin, Las Palmas Gran Canaria, Spain
[3] Univ Hosp, Madrid, Spain
[4] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[5] Hosp Univ Princesa, Madrid, Spain
[6] Univ Valencia, Gen Hosp, Valencia, Spain
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] Hosp Univ Virgen Victoria, Malaga, Spain
[9] Hosp Univ Reina Sofia, Cordoba, Spain
[10] Acad Espanola Dermatol, Madrid, Spain
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2011年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 14 条
  • [1] Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy Patients Ineligible vs Eligible for Randomized Controlled Trials
    Garcia-Doval, Ignacio
    Carretero, Gregorio
    Vanaclocha, Francisco
    Ferrandiz, Carlos
    Dauden, Esteban
    Sanchez-Carazo, Jose-Luis
    Alsina, Merce
    Herrera-Ceballos, Enrique
    Gomez-Garcia, Francisco-Jose
    Ferran, Marta
    Lopez-Estebaranz, Jose-Luis
    Hernanz, Jose-Manuel
    Belinchon-Romero, Isabel
    Vilar-Alejo, Jaime
    Rivera, Raquel
    Carrascosa, Jose-Manuel
    Carazo, Cristina
    ARCHIVES OF DERMATOLOGY, 2012, 148 (04) : 463 - 470
  • [2] Treatment modalities and risk of adverse events associated with biologic therapy: A 10-year observational review of the Australasian Psoriasis Registry
    Doolan, Brent J.
    Koye, Digsu
    Ling, Joanna
    Cains, Geoffrey D.
    Baker, Christopher
    Foley, Peter
    Dolianitis, Con
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (01) : E47 - E54
  • [3] Analysis of treatment modalities and risk of adverse events associated with biologic therapy: A 10-year observational review of the Australasian Psoriasis Registry
    Doolan, B. J.
    Koye, D.
    Dolianitis, C.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 51 - 51
  • [4] The risk of keratinocyte carcinoma (KC) in psoriasis patients receiving biologic therapy compared to conventional systemic therapy: Results from The British Association of Dermatologists Biologic Interventions Register (BADBIR)
    Mason, K. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S41 - S41
  • [5] The risk of keratinocyte carcinoma (KC) in psoriasis patients receiving biologic therapy compared with conventional systemic therapy: Results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
    Mason, Kayleigh J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 17 - 17
  • [6] Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials
    Rungapiromnan, W.
    Yiu, Z. Z. N.
    Warren, R. B.
    Griffiths, C. E. M.
    Ashcroft, D. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (04) : 890 - 901
  • [7] Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry
    Carretero, G.
    Ferrandiz, C.
    Dauden, E.
    Vanaclocha Sebastian, F.
    Gomez-Garcia, F. J.
    Herrera-Ceballos, E.
    De la Cueva-Dobao, P.
    Belinchon, I.
    Sanchez-Carazo, J. L.
    Alsina-Gibert, M.
    Lopez-Estebaranz, J. L.
    Ferran, M.
    Torrado, R.
    Carrascosa, J. M.
    Carazo, C.
    Rivera, R.
    Jimenez-Puya, R.
    Garcia-Doval, I.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (01) : 156 - 163
  • [8] A reply to: 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials'
    Amin, M.
    No, D. J.
    Wu, J. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (02) : 580 - 581
  • [9] Risk of Major Adverse Cardiovascular Events Associated with Biologic Therapies in Patients with Plaque Psoriasis: Systematic Review and Meta-Analysis of Randomised Controlled Trials
    Rungapiromnan, Watcharee
    Warren, Richard B.
    Yiu, Zenas Z. N.
    Griffiths, Christopher E. M.
    Ashcroft, Darren M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 536 - 537
  • [10] How current biologic therapies affect the risk of major adverse cardiovascular events in patients with plaque psoriasis? A systematic review and meta-analysis of randomized controlled trials
    Nartowicz, Sonia
    Jakielska, Ewelina
    Priadka, Monika
    Adamski, Zygmunt
    Ratajczak, Piotr
    Kus, Krzysztof
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (06): : 986 - 994
12